Advocacy and Thought Leadership

The George Institute is focused on effective advocacy and thought leadership to improve health, aligned to our research goals.

We are engaging with key stakeholders, sharing insights and fostering discussions to stimulate debate, guide critical health policy decisions and facilitate evidence-based change.

By working with some of the world’s leading health voices we are amplifying our work in non-communicable diseases (NCDs) and injury and improving systems for prevention and treatment.

Policy Statements and Recommendations

PHS Awards Financial COI Policy

Advocacy Networks and Partners

Latin America collaboration

Distinguished Fellows and Emerging Thought Leaders

Thought Leadership_emerging

Our activities

Search by keyword

Filter by type of content

Case studies
Events
News
Data visuals, infographics and interactives
Policy submissions, briefs and recommendations
Blogs
Podcasts
Priority areas
Videos
Blog: How medical graduates in Australia can help COVID-affected India
This blog by Senior Research Fellow Dr Rohina Joshi first appeared in Indian Link and has been republished with their permission.   India is experiencing an overwhelming second wave of COVID-19…
Profile story
Blog: How training in entrepreneurship can help Australia catch up to global innovation leaders
This article is authored by Dr Parisa Glass, Director, Innovation and Enterprise, and Kate Burling, Commercialisation and Development Manager, Innovation and Enterprise, The George Institute. It…
Profile story
Response to Government consultation on the National Preventive Health Strategy
The George Institute for Global Health is pleased to contribute to the consultation on the draft National Preventive Health Strategy.  The George Institute strongly supports the development and…
Policy and Practice Reports
Tackling the world’s biggest killers: The PILL, IMPACT, Kanyini GAP, UMPIRE & TRIUMPH studies and the SPACE Collaboration
Twenty years of ground-breaking research from The George Institute has proven the effectiveness of combining multiple medications into one pill to prevent heart attacks and strokes – the world’s…
Case Studies
Transforming treatments, saving lives: The SAFE, SAFE-TBI, CHEST & PLUS studies
Our research has saved many thousands of lives and hundreds of millions of dollars by changing the way the medical world views one of the most common intensive care treatments. Our studies have…
Case Studies
Improving Cancer Care in South East Asia: The ACTION case Study
The ACTION (Asean CosTs In Oncology) study aimed to generate unprecedented data to help policymakers protect their people and economies from cancer’s catastrophic impact. Since 2015, ACTION has…
Case Studies
The George Institute launches new podcast on world’s biggest killers: non-communicable diseases and injury
The George Institute for Global Health is delighted to announce the launch of The Scan, a new podcast exploring the latest research, emerging evidence, and progress towards improving health outcomes…
News
The wider benefits of SGLT2 inhibitors
  This report published by The George Institute, The wider benefits of SGLT2 inhibitors, shows that making SGLT2 inhibitors widely available in Australia would save lives and reduce costs to…
Policy and Practice Reports
Reducing salt to save lives: Advocacy, partnerships and research
For more than a decade, The George Institute has championed global action that has the potential to save many millions of lives and billions of dollars in healthcare costs. Our researchers have…
Case Studies
Affordability and Efficiency is the Future of Healthcare
This post was originally published on LinkedIn by Parisa Glass, Director of Innovation and Enterprise, and Professor Vlado Perkovic and is reproduced here with her kind permission.  Healthcare…
Profile story